These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Phase II study of cis-dichlorodiammineplatinum(II) in childhood osteosarcoma: Children's Cancer Study Group Report. Baum ES; Gaynon P; Greenberg L; Krivit W; Hammond D Cancer Treat Rep; 1979; 63(9-10):1621-7. PubMed ID: 291484 [No Abstract] [Full Text] [Related]
4. Evaluation of cis-dichlorodiammineplatinum(II) in children with advanced malignant diseases: Southwest Oncology Group Studies. Vietti TJ; Nitschke R; Starling KA; van Eys J Cancer Treat Rep; 1979; 63(9-10):1611-4. PubMed ID: 291482 [TBL] [Abstract][Full Text] [Related]
5. Adriamycin-cyclophosphamide and adriamycin-cis-dichloro-diammineplatinum(II) combination chemotherapy in patients with advanced cancer. Higby DJ; Wilbur D; Wallace HJ; Henderson ES; Weiss R Cancer Treat Rep; 1977 Aug; 61(5):869-73. PubMed ID: 329980 [TBL] [Abstract][Full Text] [Related]
6. cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer. Young RC; Von Hoff DD; Gormley P; Makuch R; Cassidy J; Howser D; Bull JM Cancer Treat Rep; 1979; 63(9-10):1539-44. PubMed ID: 387224 [TBL] [Abstract][Full Text] [Related]
8. Advanced ovarian carcinoma: a pilot study of cis-dichlorodiammineplatinum(II) in combination with adriamycin and cyclophosphamide in previously untreated patients and as a single agent in previously treated patients. Williams CJ; Stevenson KE; Buchanan RB; Whitehouse JM Cancer Treat Rep; 1979; 63(11-12):1745-53. PubMed ID: 393378 [No Abstract] [Full Text] [Related]
9. Clinical response and toxicity with cis-dichlorodiammineplatinum(II) in children. Kamalakar P; Freeman AI; Higby DJ; Wallace HJ; Sinks LF Cancer Treat Rep; 1977 Aug; 61(5):835-9. PubMed ID: 890692 [TBL] [Abstract][Full Text] [Related]
10. Cancer of the ovary: a summary of experience with cis-dichlorodiammineplatinum(II) at the Royal Marsden Hospital. Wiltshaw E; Subramarian S; Alexopoulos C; Barker GH Cancer Treat Rep; 1979; 63(9-10):1545-8. PubMed ID: 387225 [TBL] [Abstract][Full Text] [Related]
11. cis-Dichlorodiammineplatinum(II) and adriamycin treatment of advanced ovarian cancer. Briscoe KE; Pasmantier MW; Ohnuma T; Kennedy BJ Cancer Treat Rep; 1978 Dec; 62(12):2027-30. PubMed ID: 751711 [TBL] [Abstract][Full Text] [Related]
12. Phase II trials with cis-dichlorodiammineplatinum(II) in the treatment of urothelial cancer. Yagoda A Cancer Treat Rep; 1979; 63(9-10):1565-72. PubMed ID: 387226 [TBL] [Abstract][Full Text] [Related]
13. [Neo-adjuvant therapy in childhood osteogenic sarcoma: a pilot study of selective postoperative chemotherapy based on response to preoperative high-dose methotrexate]. Sasaki K; Matsuoka H; Murakami T; Fujimoto T; Takayanagi F; Sawai K; Niwa J; Hara K Gan To Kagaku Ryoho; 1986 May; 13(5):1837-45. PubMed ID: 3486634 [TBL] [Abstract][Full Text] [Related]
14. Phase I study of high-dose cis-dichlorodiammineplatinum(II) with forced diuresis. Chary KK; Higby DJ; Henderson ES; Swinerton KD Cancer Treat Rep; 1977; 61(3):367-70. PubMed ID: 266972 [TBL] [Abstract][Full Text] [Related]
15. cis-Dichlorodiammineplatinum(II) in non-small cell carcinoma of the lung. Gralla RJ; Cvitkovic E; Golbey RB Cancer Treat Rep; 1979; 63(9-10):1585-8. PubMed ID: 498158 [TBL] [Abstract][Full Text] [Related]
16. cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice. Schabel FM; Trader MW; Laster WR; Corbett TH; Griswold DP Cancer Treat Rep; 1979; 63(9-10):1459-73. PubMed ID: 291480 [TBL] [Abstract][Full Text] [Related]
17. Advanced bladder cancer: therapy with cis-dichlorodiammineplatinum(II), adriamycin, and 5-fluorouracil. Williams SD; Donohue JP; Einhorn LH Cancer Treat Rep; 1979; 63(9-10):1573-6. PubMed ID: 498156 [TBL] [Abstract][Full Text] [Related]
18. Phase II study of cisplatin in advanced osteogenic sarcoma. European Organization for Research on Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Gasparini M; Rouesse J; van Oosterom A; Wagener T; Somers R; Russel JA; Voƻte PA; Bramwell V; Thomas D; Sylvester R Cancer Treat Rep; 1985 Feb; 69(2):211-3. PubMed ID: 3855699 [TBL] [Abstract][Full Text] [Related]
19. Phase II trail cisplatin in refractory childhood cancer: Children's Cancer Study Group Report. Baum ES; Gaynon P; Greenberg L; Krivit W; Hammond D Cancer Treat Rep; 1981; 65(9-10):815-22. PubMed ID: 6944156 [TBL] [Abstract][Full Text] [Related]
20. cis-Dichlorodiammineplatinum(II)-based chemotherapy as initial treatment of advanced head and neck cancer. Wittes R; Heller K; Randolph V; Howard J; Vallejo A; Farr H; Harrold C; Gerold F; Shah J; Spiro R; Strong E Cancer Treat Rep; 1979; 63(9-10):1533-8. PubMed ID: 498153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]